A research team has identified STAT1 as a key transcriptional regulator that enhances platelet production from induced pluripotent stem (iPS) cells by epigenetically controlling LIN28A and its downstream let-7-RALB axis. The study, published in Blood Advances, was led by Dr. Si Jing Chen (Chiba University) and Professor Koji Eto (Department of Clinical Application)
Inhibiting STAT1 boosts platelet production via LIN28A-let-7 control
-
HighlightsFree Dark Web Monitoring Stamps the $17 Million Credentials Markets
-
HighlightsSmart buildings: What happens to our free will when tech makes choices for us?
-
AppsScreenshots have generated new forms of storytelling, from Twitter fan fiction to desktop film
-
HighlightsDarknet markets generate millions in revenue selling stolen personal data, supply chain study finds
-
SecurityPrivacy violations undermine the trustworthiness of the Tim Hortons brand
-
Featured HeadlinesWhy Tesla’s Autopilot crashes spurred the feds to investigate driver-assist technologies – and what that means for the future of self-driving cars
